Value Line - The Most Trusted Name in Investment Research - Stock Quotes

Quote Lookup

Please enter a ticker symbol below and click Submit.
Symbol:        VL Survey Page (2014-12-12)Premium Content

Biomarin Pharmac. (BMRN)

2014-12-20@22:04:15 ET
BioMarin PharmaceuticalCorporate Event Announcement Notice (WSH)

2014-12-19@21:22:16 ET
BioMarin PharmaceuticalCorporate Event Announcement Notice (WSH)

2014-12-19@11:39:30 ET
BioMarin Pharmaceutical (BMRN) Trading Near $94.33 Resistance Level (FBM)

2014-12-19@05:05:50 ET
Form 144: Filing to Sell 2000 Shares of Biomarin Pharmaceutical Inc (BMRN) (VKR)

2014-12-18@13:52:09 ET
BioMarin Pharmaceutical (BMRN) Trading Near $89.03 Resistance Level (FBM)

2014-12-18@13:27:06 ET
BioMarin Pharmaceutical Shares Climbing Higher, Up 4.0% (F77)

2014-12-18@04:24:42 ET
Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2014 (MTO)

2014-12-17@15:35:02 ET
BioMarin Pharmaceutical (BMRN) Trading Near $89.71 Resistance Level (FBM)

2014-12-17@05:06:56 ET
BioMarin receives approval for Morquio A syndrome drug from ANVISA in Brazil (DTM)

2014-12-16@10:50:37 ET
Potential BioMarin Pharmaceutical (BMRN) Trade Targets 9.07% Return (FBM)

2014-12-16@07:37:19 ET
BioMarin receives approval from TGA for treatment of Morquio A syndrome (DTM)

2014-12-15@14:52:31 ET
Trading Lower on Heavy Volume are Shares of BioMarin Pharmaceutical on 1.3x Above-Average Volume (BMRN) (F82)

2014-12-15@12:46:07 ET
Stock Investors Sell Off Shares of BioMarin Pharmaceutical, Down 2.2% (F77)

2014-12-15@10:16:15 ET
BioMarin Pharmaceutical Has Returned 22.8% Since SmarTrend Recommendation (BMRN) (PSM)

2014-12-15@10:00:58 ET
BioMarin Pharmaceutical (BMRN) Showing Support Near $89.83 (FBM)

2014-12-15@05:14:12 ET
BioMarin receives orphan drug designation from FDA for MPS IIIB drug (DTM)

2014-12-13@05:51:19 ET
Form 4: Update Filing for Biomarin Pharmaceutical Inc (BMRN) (VKR)